postherpetic neuralgia
Conditions
Interventions
Experimental group:Q(1064nm) Laser treatment
Control group:Q(532nm) Laser treatment
Sponsors
Xijing Hospital, Fourth Military Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age over 18, regardless of gender; 2. Patients with clinical diagnosis of chronic post herpetic neuralgia were judged to be stable by the researchers; 3. The routine treatment such as medicine is ineffective or the remission is not obvious; 4. The pain rating is more than 3 points according to the overall evaluation standard of the researcher; 5. Before the trial, the subject must sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Known hypersensitivity to laser spectrum; 2. Patients in acute stage 3. People with serious heart, kidney, liver, endocrine and other system diseases or with tumor and immune deficiency diseases; 4. Those who have received phototherapy, systematic drug therapy and interventional therapy with allergic reaction before the study; 5. Those who are currently participating in other clinical studies or have participated in other clinical studies within 3 months; 6. According to the judgment of the researcher, the guardian is not credible or has poor compliance. 7. Pregnant women or women with fertility plan to be pregnant or lactating during the trial period; 8. For those who are known or suspected to have poor compliance and can not complete the test, such as alcoholism, drug dependence or mental illness, the investigator judges that they are not suitable to participate in this clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale;IL- 6;substance P;ß-endorphin; | — |
Countries
China
Contacts
Public ContactFan Xing
Xijing Hospital, Fourth Military Medical University
Outcome results
None listed